Search tips
Search criteria 


Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. 1992 December; 60(12): 4989–4994.
PMCID: PMC258267

Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein.


Group B streptococci (GBS) cause the majority of cases of neonatal sepsis and meningitis in the United States. Immunization of women of childbearing age is one strategy under consideration for the prevention of neonatal disease. The beta C protein, a 130-kDa antigen present in many clinical isolates of GBS, was purified from GBS by extraction into sodium dodecyl sulfate (SDS)-containing buffer, preparative SDS-polyacrylamide gel electrophoresis, and electroelution. Purified beta C protein antigen (25 micrograms) with Freund's adjuvant was used to immunize rabbits. Rabbits developed enzyme-linked immunosorbent assay titers of > 1:1.6 x 10(6), and sera from immunized rabbits were administered to pregnant mice. Their neonatal pups were then challenged with a strain of GBS expressing beta C protein; 68% of these pups were protected by immune antiserum, whereas no controls were protected (P < 0.001). The immune serum (diluted 1:100) facilitated opsonophagocytic killing of GBS strains expressing the beta C protein but not those that do not express the antigen (mean log kill +/- standard deviation = 0.71 +/- 0.8 log10 CFU for beta+ strains and 0.09 +/- 0.2 for beta- strains; P = 0.02). In subsequent experiments, adult female mice were actively immunized with two doses of 2, 5, or 10 micrograms of beta C protein 2 months prior to mating. One- to two-day-old offspring of these dams were challenged with GBS and were protected in a dose-dependent manner, with 96% survival in the high-dose (10-micrograms) group and 20% survival in a sham-immunized control group (P < 0.001). Thus, active immunization of mice with the GBS beta C protein confers protection against lethal infection with beta+ GBS to their offspring.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics. 1981 Oct;68(4):544–549. [PubMed]
  • Baker CJ, Kasper DL. Vaccination as a measure for prevention of neonatal GBS infection. Antibiot Chemother (1971) 1985;35:281–290. [PubMed]
  • Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med. 1988 Nov 3;319(18):1180–1185. [PubMed]
  • Baltimore RS, Kasper DL, Baker CJ, Goroff DK. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol. 1977 Feb;118(2):673–678. [PubMed]
  • Bevanger L. Ibc proteins as serotype markers of group B streptococci. Acta Pathol Microbiol Immunol Scand B. 1983 Aug;91(4):231–234. [PubMed]
  • Bevanger L, Naess AI. Mouse-protective antibodies against the Ibc proteins of group B streptococci. Acta Pathol Microbiol Immunol Scand B. 1985 Apr;93(2):121–124. [PubMed]
  • Blake MS, Johnston KH, Russell-Jones GJ, Gotschlich EC. A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem. 1984 Jan;136(1):175–179. [PubMed]
  • Brady LJ, Boyle MD. Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen. Infect Immun. 1989 May;57(5):1573–1581. [PMC free article] [PubMed]
  • Brady LJ, Daphtary UD, Ayoub EM, Boyle MD. Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis. 1988 Nov;158(5):965–972. [PubMed]
  • Chun CS, Brady LJ, Boyle MD, Dillon HC, Ayoub EM. Group B streptococcal C protein-associated antigens: association with neonatal sepsis. J Infect Dis. 1991 Apr;163(4):786–791. [PubMed]
  • Givner LB, Baker CJ. The prevention and treatment of neonatal group B streptococcal infections. Adv Pediatr Infect Dis. 1988;3:65–90. [PubMed]
  • Givner LB, Edwards MS, Baker CJ. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models. J Infect Dis. 1988 Oct;158(4):724–730. [PubMed]
  • Jerlström PG, Chhatwal GS, Timmis KN. The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions. Mol Microbiol. 1991 Apr;5(4):843–849. [PubMed]
  • Johnson DR, Ferrieri P. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol. 1984 Apr;19(4):506–510. [PMC free article] [PubMed]
  • Lancefield RC, McCarty M, Everly WN. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med. 1975 Jul 1;142(1):165–179. [PMC free article] [PubMed]
  • Madoff LC, Hori S, Michel JL, Baker CJ, Kasper DL. Phenotypic diversity in the alpha C protein of group B streptococci. Infect Immun. 1991 Aug;59(8):2638–2644. [PMC free article] [PubMed]
  • Madoff LC, Michel JL, Kasper DL. A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci. Infect Immun. 1991 Jan;59(1):204–210. [PMC free article] [PubMed]
  • Michel JL, Madoff LC, Kling DE, Kasper DL, Ausubel FM. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun. 1991 Jun;59(6):2023–2028. [PMC free article] [PubMed]
  • Paoletti LC, Kasper DL, Michon F, DiFabio J, Holme K, Jennings HJ, Wessels MR. An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus. J Biol Chem. 1990 Oct 25;265(30):18278–18283. [PubMed]
  • Payne NR, Ferrieri P. The relation of the Ibc protein antigen to the opsonization differences between strains of type II group B streptococci. J Infect Dis. 1985 Apr;151(4):672–681. [PubMed]
  • Payne NR, Kim YK, Ferrieri P. Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci. Infect Immun. 1987 May;55(5):1243–1251. [PMC free article] [PubMed]
  • Rodewald AK, Onderdonk AB, Warren HB, Kasper DL. Neonatal mouse model of group B streptococcal infection. J Infect Dis. 1992 Sep;166(3):635–639. [PubMed]
  • Russell-Jones GJ, Gotschlich EC. Identification of protein antigens of group B streptococci, with special reference to the Ibc antigens. J Exp Med. 1984 Nov 1;160(5):1476–1484. [PMC free article] [PubMed]
  • Russell-Jones GJ, Gotschlich EC, Blake MS. A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen. J Exp Med. 1984 Nov 1;160(5):1467–1475. [PMC free article] [PubMed]
  • Valtonen MV, Kasper DL, Levy NJ. Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody. Microb Pathog. 1986 Apr;1(2):191–204. [PubMed]
  • Wessels MR, Paoletti LC, Kasper DL, DiFabio JL, Michon F, Holme K, Jennings HJ. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J Clin Invest. 1990 Nov;86(5):1428–1433. [PMC free article] [PubMed]
  • Wilkinson HW, Eagon RG. Type-specific antigens of group B type Ic streptococci. Infect Immun. 1971 Nov;4(5):596–604. [PMC free article] [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)